100
Participants
Start Date
December 1, 2018
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2026
Atorvastatin Calcium
20mg Qd for 12 months
Atorvastatin Calcium
40-80mg Qd for 6 months
Probucol
0.5g Bid for 6 months
PCSK9 inhibitor
Evolocumab 140mg subcutaneously injected, twice each month
RECRUITING
General Hospital of ShenYang Military Region, Shenyang
General Hospital of Shenyang Military Region
OTHER